Subscribe to Zinmag Tribune
Subscribe to Zinmag Tribune
Subscribe to Zinmag Tribune by mail

Ranbaxy Laboratories rose 3.37% to Rs 321.95 at 12:57 IST on BSE after the company received a final approval from the US drug regulator for a generic drug.
You can leave a response, or trackback from your own site.

featured-video

Blog Archive

Recent Posts

My Blog List